Treace Medical Concepts, Inc. Common Stock

TMCINASDAQUSD
4.46 USD
0.28 (5.91%)🟢LIVE (AS OF 10:04 AM EDT)
🟢Market: OPEN

TMCI is currently priced at $4.46. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, TMCI appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Aug 4, 2026.

Open?$4.73
High?$4.80
Low?$4.41
Prev. Close?$4.74
Volume?110.7K
Avg. Volume?753.5K
VWAP?$4.44
Rel. Volume?0.15x
Bid / Ask
Bid?$4.54 × 200
Ask?$4.59 × 200
Spread?$0.05
Midpoint?$4.56
Valuation & Ratios
Market Cap?307.5M
Shares Out?64.9M
Float?47.6M
Float %?73.5%
P/E Ratio?N/A
P/B Ratio?3.98
EPS?-$0.94
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
Employees
450
Market Cap
303.6M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2021-04-23
Address
100 PALMETTO PARK PLACE
PONTE VEDRA, FL 32081
Phone: (904) 373-5940
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+3/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
5
Momentum?
35
Short Sent.?
64
Piotroski F-Score?1/9Weak
Altman Z-Score?0.40Distress
Confidence?59%Low
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?3.87%Low
Short Interest?1.8M
Days to Cover?3.6
Free Float47.6M
Avg Daily Volume515.2K
Settlement Date2026-07-15
Financial Health
Current Ratio?3.58Strong
Quick Ratio?2.53Strong
Cash Ratio?0.28Low
Debt/Equity?0.72Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A
P/B?
Peers
100
S&P
45
3.98FAIR
P/S?
Peers
100
S&P
79
1.48CHEAP
P/FCF?
N/A
EV/EBITDA?
S&P
97
-7.6CHEAP
EV/Sales?
Peers
100
S&P
80
1.71CHEAP
Returns & Efficiency
ROE?
S&P
3
-79.1%WEAK
ROA?
S&P
3
-33.2%WEAK
Cash Flow & Enterprise
FCF?$-25964000
Enterprise Value?$353.8M
Fundamentals ratios updated end of day